Insider · CIK 0001851630

Griffiths Graham

Reports to the SEC for 1 company · DIDCOT, X0

sec.gov

Transactions

Companies

Filings

CIK

0001851630

Forms 4 and 5

Insider transactions

28 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-02-03	BRNSBarinthus Biotherapeutics plc. · Share Option (Right to Buy)A Award	Chief Business Officer	AAward	+200K sh	—	—	200,000
2024-01-02	BRNSBarinthus Biotherapeutics plc. · Share Option (Right to Buy)A Award	Chief Business Officer	AAward	+96.5K sh	—	—	96,500
2023-01-03	BRNSBarinthus Biotherapeutics plc. · Share Option (Right to Buy)A Award	Chief Business Officer	AAward	+105K sh	—	—	105,000
2022-08-25	BRNSBarinthus Biotherapeutics plc.S Sale	Chief Business Officer	SSale	−10K sh	$7.39	−$73.9K	104,209
2022-08-17	BRNSBarinthus Biotherapeutics plc.S Sale	Chief Business Officer	SSale	−500 sh	$4.76	−$2,381	114,209
2022-08-16	BRNSBarinthus Biotherapeutics plc.S Sale	Chief Business Officer	SSale	−1,220 sh	$4.82	−$5,876.374	114,709
2022-08-15	BRNSBarinthus Biotherapeutics plc.S Sale	Chief Business Officer	SSale	−2,400 sh	$4.75	−$11.4K	115,929
2022-08-12	BRNSBarinthus Biotherapeutics plc.S Sale	Chief Business Officer	SSale	−5,000 sh	$4.50	−$22.5K	118,329
2022-06-24	BRNSBarinthus Biotherapeutics plc.L Small Acquisition	Chief Business Officer	LSmall Acquisition	+100 sh	$5.87	+$586.8	123,329
2022-06-23	BRNSBarinthus Biotherapeutics plc. · Share Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−3,090 sh	—	—	6,180
2022-06-23	BRNSBarinthus Biotherapeutics plc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+2,317 sh	$0.00	+$0.927	120,147
2022-06-23	BRNSBarinthus Biotherapeutics plc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+3,090 sh	$0.00	+$1.236	123,237
2022-06-23	BRNSBarinthus Biotherapeutics plc.S Sale	Chief Business Officer	SSale	−8 sh	$5.28	−$42.24	123,229
2022-06-23	BRNSBarinthus Biotherapeutics plc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+1,931 sh	$0.00	+$0.772	117,830
2022-06-23	BRNSBarinthus Biotherapeutics plc. · Share Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−1,931 sh	—	—	0
2022-06-23	BRNSBarinthus Biotherapeutics plc. · Share Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−2,317 sh	—	—	2,317
2022-01-03	BRNSBarinthus Biotherapeutics plc. · Share Option (Right to Buy)A Award	Chief Business Officer	AAward	+80K sh	—	—	80,000
2021-12-17	BRNSBarinthus Biotherapeutics plc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+3,090 sh	$0.00	+$1.236	115,899
2021-12-17	BRNSBarinthus Biotherapeutics plc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+4,636 sh	$0.00	+$1.854	112,809
2021-12-17	BRNSBarinthus Biotherapeutics plc. · Share Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−5,794 sh	—	—	1,931
2021-12-17	BRNSBarinthus Biotherapeutics plc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+5,794 sh	$0.00	+$2.318	108,173
2021-12-17	BRNSBarinthus Biotherapeutics plc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+102K sh	$0.00	+$40.912	102,379
2021-12-17	BRNSBarinthus Biotherapeutics plc. · Share Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−102K sh	—	—	0
2021-12-17	BRNSBarinthus Biotherapeutics plc. · Share Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−3,090 sh	—	—	9,270
2021-12-17	BRNSBarinthus Biotherapeutics plc. · Share Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−4,636 sh	—	—	4,634
2021-05-04	BRNSBarinthus Biotherapeutics plc.P Purchase	Chief Business Officer	PPurchase	+100 sh	$17.00	+$1,700	100
2021-04-29	BRNSBarinthus Biotherapeutics plc. · Share Option (Right to Buy)A Award	Chief Business Officer	AAward	+88.1K sh	—	—	88,065
2021-04-29	BRNSBarinthus Biotherapeutics plc. · Share Option (Right to Buy)A Award	Chief Business Officer	AAward	+6,054 sh	—	—	6,054

Recent filings

Accepted (ET)
Feb 54
Griffiths Graham0001828185-25-000010
SEC(opens sec.gov)
Jan 44
Griffiths Graham0001104659-24-001166
SEC(opens sec.gov)
Feb 234
Griffiths Graham0001104659-23-024805
SEC(opens sec.gov)
Aug 264
Griffiths Graham0001104659-22-095144
SEC(opens sec.gov)
Aug 194
Griffiths Graham0001104659-22-092959
SEC(opens sec.gov)
Aug 174
Griffiths Graham0001104659-22-092176
SEC(opens sec.gov)
Aug 154
Griffiths Graham0001104659-22-091265
SEC(opens sec.gov)
Jul 154
Griffiths Graham0001104659-22-080206
SEC(opens sec.gov)
Feb 115
Griffiths Graham0001104659-22-020827
SEC(opens sec.gov)

Companies

Barinthus Biotherapeutics plc.Chief Business OfficerBRNS

Address

UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL

DIDCOT, X0, OX11 0DF